Catherine Novack
Stock Analyst at Jones Trading
(1.24)
# 3,667
Out of 5,044 analysts
21
Total ratings
27.78%
Success rate
-7.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $12.00 | +175.00% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $24.29 | +23.51% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $6.18 | +369.26% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.66 | +808.82% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.62 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $73.50 | -38.78% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.85 | +285.96% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $40.08 | +224.35% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.35 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $7.59 | +110.80% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.35 | +221.84% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.03 | +540.39% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.49 | +5.37% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.11 | +607.40% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.25 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.58 | +27,344.25% | 1 | Jul 21, 2023 |
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $12.00
Upside: +175.00%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $24.29
Upside: +23.51%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $6.18
Upside: +369.26%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.66
Upside: +808.82%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $73.50
Upside: -38.78%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.85
Upside: +285.96%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $40.08
Upside: +224.35%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.35
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.59
Upside: +110.80%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.35
Upside: +221.84%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.03
Upside: +540.39%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $9.49
Upside: +5.37%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.11
Upside: +607.40%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.25
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.58
Upside: +27,344.25%